jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Heart valves biopsy

Biopsy
image

Report in 240Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Histopathology of excised valve.

₹296₹423

30% OFF

Heart Valves Biopsy - Comprehensive Medical Test Information Guide

  • Why is it done?
    • Test Measurement: A heart valves biopsy involves the microscopic examination of tissue samples obtained from one or more of the heart's four valves (aortic, mitral, pulmonary, or tricuspid) to identify pathological changes, infections, inflammatory conditions, or structural abnormalities at the cellular and tissue level.
    • Primary Indications for Testing:
    • • Suspected infective endocarditis with positive blood cultures • Diagnosis of valvular vegetations of unclear etiology • Evaluation of native or prosthetic valve dysfunction • Investigation of rheumatic heart disease • Assessment of myxomatous (degenerative) valve disease • Suspected cardiac myxomas or other primary cardiac tumors • Evaluation of radiation-induced valve damage • Investigation of drug-induced valve pathology • Assessment of congenital valve abnormalities
    • Typical Timing and Circumstances:
    • • Performed during cardiac surgical procedures (valve replacement, repair, or vegetectomy) • Typically obtained during urgent or elective cardiac surgery when valve pathology is suspected • May be performed during transesophageal echocardiography-guided interventions • Timing depends on clinical urgency and diagnostic uncertainty regarding valve disease • Often indicated when non-invasive imaging results are inconclusive or contradictory
  • Normal Range
    • Reference/Normal Findings:
    • • Normal valve structure: Intact endocardium with normal collagen fibers and elastic fibers • Normal cellularity: Sparse fibroblasts, absence of inflammatory cells • Normal architecture: Organized collagen matrix with appropriate trilaminar structure (fibrosa, spongiosa, ventricularis) • Absence of: Bacterial/fungal organisms, inflammatory infiltrates, neoplastic cells, thrombotic material • Histochemical stains: Negative for microorganisms (Gram, GMS, PAS stains) • Immunohistochemistry: Negative for specific pathogens or malignant markers
    • How to Interpret Results:
    • Negative/Normal Result:
    • - Indicates normal histological architecture - No evidence of infection, inflammation, or malignancy - Rules out endocarditis if biopsied valve tissue lacks vegetative material - No pathogenic organisms identified - Supports functional/degenerative valve disease diagnosis
    • Positive Result:
    • - Abnormal histological findings present - May indicate specific pathological diagnosis - Requires clinical correlation with echocardiography and laboratory data - May guide antibiotic or antifungal therapy selection
    • Units of Measurement:
    • • Histological findings: Reported as descriptive pathology (presence/absence of specific features) • Inflammation grading: Mild, moderate, or severe inflammatory infiltrate • Organism quantification: Identified and speciated (when detected) • Tissue involvement: Expressed as percentage of tissue affected or extent of lesion (focal vs. diffuse)
    • Normal vs. Abnormal Meaning:
    • Normal: Preserved valve histology indicates healthy tissue with minimal disease pathology; suggests non-infectious etiology if valve dysfunction present Abnormal: Identifies specific disease process requiring targeted treatment; establishes definitive diagnosis for infectious, inflammatory, or neoplastic conditions
  • Interpretation
    • Detailed Interpretation of Result Values:
    • Infective Endocarditis (Positive Finding):
    • - Presence of vegetations: Fibrin, platelet deposits, inflammatory cells, and organisms - Identifies causative organism: Bacterial species (Streptococcus, Staphylococcus, Enterococcus), Fungal species (Candida, Aspergillus), or fastidious organisms - Valve perforation or destruction: Indicates severe infection with tissue necrosis - Abscess formation: Indicates invasive endocarditis - Culture/PCR positive: Confirms organism isolation and antibiotic susceptibility testing
    • Rheumatic Heart Disease (Positive Finding):
    • - Aschoff bodies: Pathognomonic finding indicating active rheumatic carditis - Chronic changes: Fibrosis, collagen deposition, calcification - Valve commissural fusion: Indicates long-standing disease - Inflammatory infiltrate: Lymphocytes and macrophages indicate active inflammation
    • Degenerative Valve Disease (Positive Finding):
    • - Myxomatous changes: Disrupted collagen and elastic fibers with spongiosa expansion - Calcification: Dystrophic calcium deposition in valve substance - Fibrosis and collagen disorganization: Indicates chronic wear and tear - Minimal inflammation: Distinguishes from inflammatory etiologies - Prolapse findings: Abnormal valve leaflet architecture
    • Prosthetic Valve Pathology (Positive Finding):
    • - Pannus formation: Ingrowth of fibrous tissue causing valve stenosis - Structural deterioration: Wear of prosthetic material - Thrombosis: Fibrin and platelet deposition - Infection on prosthetic: Bacterial or fungal colonization - Suture-related complications: Tears or dehiscence at attachment sites
    • Factors Affecting Interpretation:
    • • Sample adequacy: Sufficient tissue quantity affects diagnostic yield • Sampling location: Biopsy site (valve leaflet, annulus, chordae) influences findings • Prior antibiotic therapy: May reduce organism recovery rate • Timing of biopsy: Early vs. late endocarditis affects histological appearance • Associated conditions: Renal disease, systemic lupus erythematosus, malignancy may affect valve pathology • Age-related changes: Degenerative changes increase with age • Previous cardiac procedures: May show organizing thrombus or foreign body reaction
    • Clinical Significance of Result Patterns:
    • • Pathognomonic findings (Aschoff bodies, characteristic vegetations): Establish definitive diagnosis • Nonspecific findings: Require clinical correlation with imaging and serology • Mixed histological patterns: Suggest multiple concurrent processes (e.g., endocarditis superimposed on rheumatic disease) • Negative biopsy with positive blood cultures: Suggests blood culture contamination or sampling error • Findings not matching clinical suspicion: Indicates need for alternative diagnostic approaches
  • Associated Organs
    • Primary Organ System Involved:
    • • Cardiovascular system (primary): All four heart valves (aortic, mitral, pulmonary, tricuspid) and associated structures • Endocardium: Innermost layer of heart where valves originate • Myocardium: May be involved in severe inflammatory or infectious processes • Heart conduction system: May be compromised in severe endocarditis • Coronary arteries: May be affected by emboli in endocarditis
    • Medical Conditions Associated with Abnormal Results:
    • • Infective endocarditis (bacterial, fungal, culture-negative) • Acute rheumatic fever and rheumatic heart disease • Myxomatous/prolapse valvular disease • Degenerative aortic stenosis • Calcific valve disease • Prosthetic valve complications (thrombosis, pannus, infection) • Carcinoid syndrome (endocardial involvement) • Primary cardiac lymphoma • Cardiac myxoma • Marfan syndrome valve involvement • Systemic lupus erythematosus (SLE) valve disease • Antiphospholipid syndrome • Drug-induced valve disease (fenfluramine, phentermine, methysergide) • Radiation-induced heart disease • HIV-related valve disease • Behçet's disease • Systemic sclerosis
    • Diseases This Test Helps Diagnose:
    • • Infective endocarditis: Definitive organism identification and species confirmation • Rheumatic heart disease: Identification of Aschoff bodies and characteristic rheumatic changes • Active carditis: Assessment of inflammatory burden and severity • Valve tumors: Histological classification and determination of benign vs. malignant nature • Culture-negative endocarditis: Identification of fastidious organisms or microorganisms not culturable • Prosthetic valve dysfunction: Differentiation between mechanical failure and infection • Rare valve pathologies: Identification of unusual or unexpected valve diseases
    • Potential Complications/Risks Associated with Abnormal Results:
    • From Infective Endocarditis:
    • - Septic embolization to lungs, brain, spleen, kidneys - Valve perforation and acute regurgitation - Cardiac abscess formation - Conduction abnormalities and heart block - Acute heart failure - Cardiogenic shock
    • From Rheumatic Heart Disease:
    • - Progressive valve stenosis and regurgitation - Atrial fibrillation - Thromboembolism - Chronic heart failure - Need for valve replacement surgery
    • From Malignant Findings:
    • - Metastatic dissemination - Sudden cardiac death - Hemodynamic instability - Need for chemotherapy or additional surgical intervention
  • Follow-up Tests
    • Additional Tests Based on Biopsy Results:
    • If Endocarditis Confirmed:
    • - Antibiotic susceptibility testing: Determines appropriate antibiotic therapy - Minimum inhibitory concentration (MIC): Guides antibiotic dosing - Repeat blood cultures: Assesses effectiveness of therapy - Serial transthoracic echocardiography (TTE): Monitors valve function and abscess resolution - Cardiac MRI: Evaluates extent of myocardial involvement - PET-CT scan: Identifies infectious foci and septic emboli - Electrocardiography (ECG): Monitors for conduction abnormalities
    • If Rheumatic Heart Disease Confirmed:
    • - Chest X-ray: Evaluates cardiac size and pulmonary edema - Doppler echocardiography: Quantifies stenosis and regurgitation - ECG: Assesses for atrial fibrillation and left atrial enlargement - Streptococcal serology (ASO titer, anti-DNase B): Confirms prior streptococcal infection - Infectious disease consultation: For long-term management recommendations
    • If Malignancy Identified:
    • - Cardiac MRI and CT: Assesses tumor size and extent - Chest/abdomen/pelvis imaging: Evaluates for metastases - Tumor markers: CEA, CA-125 (depending on malignancy type) - Oncology consultation: Determines need for chemotherapy - Follow-up imaging surveillance: Monitors for recurrence
    • Further Investigations That Might Be Needed:
    • • Immunohistochemistry on biopsy specimen: Further characterizes cell types and pathogenic markers • Molecular testing (PCR, 16S rRNA): Identifies atypical or unculturable microorganisms • Flow cytometry: Determines if malignant cells are present • Fluorescence in situ hybridization (FISH): Identifies chromosomal abnormalities in malignant cells • Electron microscopy: Evaluates ultrastructural changes • Metabolic cardiac imaging (PET scan): Assesses myocardial viability in heart failure
    • Monitoring Frequency for Ongoing Conditions:
    • Acute Endocarditis (Treated):
    • - Transthoracic echocardiography: Week 1, then every 3-4 weeks during antibiotic therapy - Blood cultures: Weeks 1 and 4 of treatment to assess sterilization - After treatment completion: Baseline echocardiogram for future comparison
    • Rheumatic Heart Disease:
    • - Echocardiography: Every 1-2 years in asymptomatic patients with mild disease - Every 6-12 months in moderate disease - Every 3-6 months if severe valve dysfunction - Annual cardiology evaluation
    • Post-Cardiac Surgery:
    • - Immediate postoperative echocardiography (Day 1-3) - Discharge echocardiography (before hospital discharge) - 6-week follow-up imaging - Annual surveillance echocardiography
    • Related Tests Providing Complementary Information:
    • • Transthoracic echocardiography (TTE): Non-invasive assessment of valve morphology and function • Transesophageal echocardiography (TEE): Superior visualization of valve details and vegetations • Blood cultures: Identification of circulating organisms causing endocarditis • Electrocardiography: Detection of conduction abnormalities • Chest radiography: Evaluation of cardiac silhouette and pulmonary status • Cardiac MRI: High-resolution tissue characterization • Cardiac CT: Assessment of calcification and structural anatomy • Biomarkers (troponin, BNP, procalcitonin): Indicators of myocardial damage or inflammation • Serologic testing: Streptococcal antibodies, ANA, antiphospholipid antibodies for systemic diseases • Inflammatory markers (CRP, ESR): Assessment of ongoing inflammation
  • Fasting Required?
    • Fasting Requirement:
    • NO - Fasting is NOT required for heart valves biopsy
    • Rationale: Heart valve biopsy is a surgical procedure involving tissue sampling during open-heart surgery or catheter-based intervention, not a serum laboratory test. Fasting is not required for the biopsy procedure itself.
    • Special Instructions and Patient Preparation:
    • Pre-operative Fasting (if scheduled surgery):
    • - NPO (nothing by mouth) for 6-8 hours before scheduled cardiac surgery - This fasting requirement is for general/regional anesthesia, NOT for the biopsy test itself - Follow specific institution's preoperative NPO guidelines
    • Medications to Avoid:
    • • Anticoagulants: Warfarin (typically stopped 3-5 days prior), direct oral anticoagulants (DOACs) as directed by surgeon • Antiplatelet agents: Aspirin may need adjustment; clopidogrel (Plavix) typically stopped 5-7 days prior unless high-risk coronary stent present • Nonsteroidal anti-inflammatory drugs (NSAIDs): Discontinue 1-2 weeks prior due to bleeding risk • Herbal supplements: Ginkgo biloba, garlic, ginger (may increase bleeding risk) • Blood thinner supplements: Coenzyme Q10, omega-3 fatty acids (high doses) - consult surgeon
    • Medications to Continue:
    • • Beta-blockers: Continue unless specifically instructed otherwise • ACE inhibitors: May be continued or held day of surgery per surgeon preference • Antibiotic prophylaxis: May be administered preoperatively • Cardiac medications: Generally continued with small sip of water • Take prescribed medications with minimal water (2-3 oz) 2-4 hours before surgery if instructed
    • Other Patient Preparation Requirements:
    • Physical Preparation:
    • - Shower/bathe night before surgery with antimicrobial soap (chlorhexidine or povidone-iodine) - Remove nail polish, makeup, and cosmetics - Empty bladder before preoperative medications administered - Remove dentures, hearing aids, contact lenses, prosthetics (stored safely) - Wear hospital gown - Remove all jewelry, piercings, and body jewelry - Shave surgical site per institution protocol (may not be necessary)
    • Laboratory Testing Before Procedure:
    • - Complete blood count (CBC): Evaluates hemoglobin and platelet count - Coagulation studies (PT/INR, PTT): Assesses bleeding risk - Blood type and crossmatch: For possible transfusion during surgery - Renal function (BUN, creatinine): Evaluates kidney function - Electrolytes: Baseline sodium, potassium, chloride, CO2 - Blood glucose: Important in diabetic patients - Liver function tests: Baseline hepatic assessment - Blood cultures (if endocarditis suspected): Before any antibiotics administered - Transthoracic or transesophageal echocardiography: If not recently performed
    • Imaging Studies:
    • - Chest X-ray: Baseline cardiac and pulmonary assessment - Electrocardiography (ECG): Baseline rhythm and ischemic changes - Cardiac catheterization: May be performed preoperatively in select cases
    • Informational Requirements:
    • - Informed consent: Review and sign operative consent form - Risk acknowledgment: Understand procedure risks (bleeding, infection, need for reoperation) - Medication list review: Verify all medications, supplements, and allergies with surgical team - Allergy confirmation: Confirm drug allergies and anesthesia allergies - Baseline functional assessment: Report current symptoms and exercise tolerance - Arrange transportation: Obtain ride home; cannot drive after anesthesia - Time-off planning: Arrange time off work for recovery (typically 4-6 weeks for cardiac surgery)
    • Day of Procedure Instructions:
    • - Arrive 1-2 hours before scheduled surgery time • NPO status maintained (nothing by mouth) • Empty bladder immediately before preoperative medications • Remove all metal objects and prosthetics • Wear hospital gown and non-slip socks • Report any last-minute concerns to preoperative staff • Expect intravenous (IV) line placement • Expect preoperative medications for relaxation and anxiety reduction

How our test process works!

customers
customers